The FDA has granted orphan drug designation (ODD) to a locally delivered formulation of irinotecan (ChemoSeed) for the ...
Q4 2025 Earnings Call March 19, 2026 8:00 AM EDTCompany ParticipantsJin Li - Head of Investor RelationsLong Chen - Founder, ...
In recent years, the baker’s yeast market has experienced notable growth driven by increasing demand for bakery products such ...
KORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2025 Earnings Call Transcript March 12, 2026 KORU Medical Systems, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.02.
The Riverhead Town Board granted preliminary site plan approval Tuesday for a five-story addition to the Zenith Building on McDermott Avenue.
Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results